Artificial intelligence and the proliferation of healthcare data have made it possible for medtech to consider not just individual patients as their ultimate customers, but entire populations, the DeviceTalks panelists said. The industry would also do well to seek collaborations with not only the established experts in particular areas of medicine, but younger, hungrier physicians and researchers who want to make a name for themselves, they advised.
“The last decade or so has seen a steady proliferation of ethnographic, human-centered design methodologies. This has led to a number of critical breakthroughs in several therapeutic areas,” said Shayan Bhattacharyya, director of strategic partnerships for Blue Health Intelligence, an arm of the Blue Cross Blue Shield system. “I think the next horizon will be to expand that philosophy to include the perspective of other stakeholders, such as payers. Insights derived from big data analytics, such as what we have Blue Health Intelligence, will be critical in enabling that process.”
Get the full story on our sister site, Medical Design & Outsourcing.
The post Medtech companies need to expand their philosophy: Here’s why appeared first on MassDevice.
from MassDevice https://ift.tt/2LM0civ
Cap comentari:
Publica un comentari a l'entrada